Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Owen Williams

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Cancers|December 17, 2024
Synergistic Strategies for KMT2A-Rearranged Leukemias: Beyond Menin InhibitorSandra Cantilena, Mohamed AlAmeri, Noelia Che, et al.
Leukemia Research|July 25, 2009
The RAC specific guanine nucleotide exchange factor Asef functions downstream from TEL-AML1 to promote leukaemic transformationRuth Lyons, Owen Williams, Michelle Morrow, et al.
Disability and Rehabilitation|April 18, 2024
Exploring access to community neurorehabilitation for people with progressive neurological conditions: a qualitative studyShona J Pryde, Owen Williams, Margaret P O'Hare, et al.
Blood|January 17, 2004
TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activityMichelle Morrow, Sarah Horton, Dimitris Kioussis, et al.
European Journal of Immunology|November 15, 2002
Inefficient clustering of tyrosine-phosphorylated proteins at the immunological synapse in response to an antagonist peptideLesley A Smyth, Laurence Ardouin, Owen Williams, et al.
Blood|June 7, 2013
STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemiaMaurizio Mangolini, Jasper de Boer, Vanessa Walf-Vorderwülbecke, et al.
Cancer Research|October 3, 2008
Development of cellular immune responses against PAX5, a novel target for cancer immunotherapyMengyong Yan, Nourredine Himoudi, Martin Pule, et al.
Experimental Hematology & Oncology|August 16, 2024
Enhanced depletion of MLL-fusion proteins in acute leukemia: potential for improved therapeutic outcomesNoelia Che, Sandra Cantilena, Remi Looi-Somoye, et al.
Blood|November 26, 2008
Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalitiesSarah J Horton, Vanessa Walf-Vorderwülbecke, Steve J Chatters, et al.
Nature Communications|June 7, 2014
Dynamic haematopoietic cell contribution to the developing and adult epicardiumGemma M Balmer, Sveva Bollini, Karina N Dubé, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Cancers|December 17, 2024
Synergistic Strategies for KMT2A-Rearranged Leukemias: Beyond Menin InhibitorSandra Cantilena, Mohamed AlAmeri, Noelia Che, et al.
Leukemia Research|July 25, 2009
The RAC specific guanine nucleotide exchange factor Asef functions downstream from TEL-AML1 to promote leukaemic transformationRuth Lyons, Owen Williams, Michelle Morrow, et al.
Disability and Rehabilitation|April 18, 2024
Exploring access to community neurorehabilitation for people with progressive neurological conditions: a qualitative studyShona J Pryde, Owen Williams, Margaret P O'Hare, et al.
Blood|January 17, 2004
TEL-AML1 promotes development of specific hematopoietic lineages consistent with preleukemic activityMichelle Morrow, Sarah Horton, Dimitris Kioussis, et al.
European Journal of Immunology|November 15, 2002
Inefficient clustering of tyrosine-phosphorylated proteins at the immunological synapse in response to an antagonist peptideLesley A Smyth, Laurence Ardouin, Owen Williams, et al.
Blood|June 7, 2013
STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemiaMaurizio Mangolini, Jasper de Boer, Vanessa Walf-Vorderwülbecke, et al.
Cancer Research|October 3, 2008
Development of cellular immune responses against PAX5, a novel target for cancer immunotherapyMengyong Yan, Nourredine Himoudi, Martin Pule, et al.
Experimental Hematology & Oncology|August 16, 2024
Enhanced depletion of MLL-fusion proteins in acute leukemia: potential for improved therapeutic outcomesNoelia Che, Sandra Cantilena, Remi Looi-Somoye, et al.
Blood|November 26, 2008
Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalitiesSarah J Horton, Vanessa Walf-Vorderwülbecke, Steve J Chatters, et al.
Nature Communications|June 7, 2014
Dynamic haematopoietic cell contribution to the developing and adult epicardiumGemma M Balmer, Sveva Bollini, Karina N Dubé, et al.
Pageof 6